Skip to main content

Thuis

/

Kenniscentrum

/

Nieuws en bronnen

Nieuws en Achtegronden

Lees onze nieuwste inzichten en achtergrondinformatie, waaronder bedrijfsupdates, artikelen, whitepapers, casestudies, webinars en meer.

Case Study

Metabolic

Driving Engagement, Improving Outcomes: The Impact of Virtual Registered Dietitian Support in Metabolic Trials

In obesity and metabolic clinical trials, some of the biggest threats to success aren’t found in the protocol. They happen between study visits. Lifestyle changes, side effect management, and long-term behavioral adjustments can all influence patient retention, adherence, and ultimately study outcomes. Learn how EmVenio’s virtual Registered Dietitian model helped bridge these gaps in ongoing […]

Article

Infographic: The Triple Effect of CBCTs

Community-based clinical trials offer more than just improved access. They create a ripple effect across study performance. By bringing research closer to patients, sponsors can unlock what we call the “Triple Effect”: higher enrollment, lower attrition, and more representative data. Get the highlights by downloading the infographic below: Read the full article here: The Triple […]

Blog

Redesigning Reach: Community-Based Research In Action – Part 4

Throughout this series, we’ve explored the growing adoption of community-based research, examined barriers to implementation, and discussed what organizations need to successfully operationalize these models. In this final installment, we focus on where community-based research is already demonstrating impact and which therapeutic areas are best positioned for continued growth. In partnership with Citeline, we surveyed […]

2026 World Vaccine Congress Roundtable

Efforts to improve clinical trial access and representation have expanded significantly in recent years, yet participation gaps persist. The discussion highlights how trust, community influence, and patient experience are increasingly shaping trial participation. It also underscores the need to move beyond treating communication as a downstream activity and instead embed it into trial design, engagement […]

Navigating regulatory complexity: Key insights from industry leaders on ICH GP R3 and global compliance

Text placeholder xxx

Blog

Lower Attrition Rates = Trials Completed Sooner

Clinical trials fall behind schedule long before deadlines are missed. Attrition builds gradually as patients encounter repeated barriers to participation. In traditional trial models, those barriers are often logistical- travel distance, time away from work or family, and the burden of returning to unfamiliar sites over the course of a study. Community-based clinical trials address this at the level […]

Article

From Data Collection to Decision-Making in Clinical Trials

Clinical trials are generating unprecedented volumes of data, yet translating that data into timely, confident decisions remains a persistent challenge. This executive summary captures insights from the 2026 SCOPE Roundtable featuring experts from Biogen, Veristat, Endeavor BioMedicines, Contraline, and EmVenio Clinical Research. Together, they explore how protocol design, real-time visibility, AI governance, and stronger system […]

Blog

Showing Up Where It Matters: Juneteenth ATL 2026

The Juneteenth ATL Parade & Music Festival is a vibrant, three-day celebration of freedom, culture, and community held in the heart of Atlanta. This year, our team partnered with Sanofi to engage directly with attendees and expand awareness of clinical research through approachable, in-person conversations. Gaps in clinical trial representation persist, particularly among communities of color […]

Increased Reach & Awareness = Faster Enrollment

The biggest barrier to enrollment isn’t eligibility, it’s access. Most clinical trials don’t struggle because patients don’t exist- they struggle because patients can’t easily participate. Traditional site models often require patients to travel significant distances, reducing access and constraining enrollment from the start. Community-based clinical trials change that dynamic by expanding where trials take place. Instead of asking patients to come to the trial, CBCTs bring the trial […]

Article

The Triple Effect of Community-Based Clinical Trials

Community-based clinical trials are no longer a future concept—they’re an underutilized advantage. As decentralized clinical trials (DCTs) and site networks continue to gain momentum, “community based trials” are increasingly part of the conversation. Yet despite the attention, many sponsors still hesitate to adopt them at scale. So what’s holding them back? Continue reading by filling […]

Honoring Cancer Survivors: This Month and Always

Every June, National Cancer Survivor Month invites us to celebrate resilience, honor survivorship, and recognize the ongoing needs of millions of people living with and beyond cancer. Today, more than 18 million individuals in the United States are navigating life after diagnosis—each with a unique journey shaped by treatment, recovery, and long-term care needs. Advancing Survivorship Through […]

Blog

Redesigning Reach: Community-Based Research In Action – Part 3

As our series on community‑based research continues, one thing is clear: the industry is aligned on the promise – but still working through execution. In partnership with Citeline, we surveyed 130 leaders from biotech companies, pharmaceutical organizations and CROs to understand how community‑centric models are being evaluated in practice. In previous articles, we explored key […]